Patents by Inventor Cherylea Browne

Cherylea Browne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electroporation system for controlled localized therapeutics delivery
    Patent number: 11213671
    Abstract: Embodiments of the present invention provide an electroporation system comprising an electroporation probe having at least two contiguous electrodes configured to be inserted into biological tissue for electroporation treatment, and a pulse generator electrically connected to the probe and configured to drive the electroporation probe using a sequence of one or more electric pulses to cause current transmission through the probe and induce a non-uniform electric field in the biological tissue proximate the probe electrodes. Treatment tissue can be targeted by controlling the probe configuration, carrier solution characteristics and parameters of the electroporation pulse sequence to achieve predictable electroporation outcomes. This electroporation control method can also reduce potentially toxic effects of electroporation treatment.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: January 4, 2022
    Assignee: NewSouth Innovations Pty Limited
    Inventors: Gary David Housley, Nigel Hamilton Lovell, Jeremy Pinyon, Edward Norman Crawford, Cherylea Browne
  • ELECTROPORATION SYSTEM FOR CONTROLLED LOCALIZED THERAPEUTICS DELIVERY
    Publication number: 20180169399
    Abstract: Embodiments of the present invention provide an electroporation system comprising an electroporation probe having at least two contiguous electrodes configured to be inserted into biological tissue for electroporation treatment, and a pulse generator electrically connected to the probe and configured to drive the electroporation probe using a sequence of one or more electric pulses to cause current transmission through the probe and induce a non-uniform electric field in the biological tissue proximate the probe electrodes. Treatment tissue can be targeted by controlling the probe configuration, carrier solution characteristics and parameters of the electroporation pulse sequence to achieve predictable electroporation outcomes. This electroporation control method can also reduce potentially toxic effects of electroporation treatment.
    Type: Application
    Filed: June 24, 2016
    Publication date: June 21, 2018
    Inventors: Gary David Housley, Nigel Hamilton Lovell, Jeremy Pinyon, Edward Norman Crawford, Cherylea Browne